Heregulin-dependent autocrine loop regulates growth of K-ras but not erbB-2 transformed rat thyroid epithelial cells

Journal of Cellular Physiology

Volumn 176, Issue 2, 1998, Pages 383-391

  Mincione, Gabriella ^a   Piccirelli, Alessandro ^a   Lazzereschi, Davide ^b   Salomon, David S ^c   Colletta, Giulia ^a  

^a UNIVERSITY OF CHIETI   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEU DIFFERENTIATION FACTOR; ONCOPROTEIN; ONCOPROTEIN K RAS; THYROTROPIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; AUTOCRINE EFFECT; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CELL TRANSFORMATION; CONTROLLED STUDY; NONHUMAN; ONCOGENE K RAS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; THYROID CELL;

ANIMALS; ANTIBODIES; ANTINEOPLASTIC AGENTS; AUTOCRINE COMMUNICATION; BINDING, COMPETITIVE; BREAST NEOPLASMS; CARRIER PROTEINS; CELL LINE, TRANSFORMED; COLONIC NEOPLASMS; EPIDERMAL GROWTH FACTOR; EPITHELIAL CELLS; GENE EXPRESSION; GLYCOPROTEINS; GROWTH SUBSTANCES; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MEMBRANE GLYCOPROTEINS; NEOPLASM PROTEINS; NEUREGULIN-1; NEUTRALIZATION TESTS; PROTO-ONCOGENE PROTEINS; RAS PROTEINS; RATS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; RECEPTOR, ERBB-3; RNA, MESSENGER; THYROID GLAND; TUMOR CELLS, CULTURED;

ANIMALIA;

EID: 0031873751     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4652(199808)176:2<383::AID-JCP17>3.0.CO;2-4     Document Type: Article

References (42)

1. Aasland, R., Lillehaug, J.R., Male, R., Josendal, O., Varhaug, J.E., and Kleppe, K. (1988) Expression of oncogenes in thyroid tumors: Coexpression of c-erbB-2/neu and c-erbB-1. Br. J. Cancer, 57:358-363.
2. Aasland, R., Akslen, L.A., Varhaug, J.E., and Lillehaug, J.R. (1990) Coexpression of the genes encoding TGFa and its receptor in papillary carcinomas of the thyroid. Int. J. Cancer, 46:382-387.
3. Alroy, I., and Yarden, Y. (1997) The erbB signaling network in embryogenesis and oncogenesis: Signal diversification through combinatorial ligand-receptor interactions. FEBS Letters, 410:83-86.
4. Ambesi-Impiombato, F.S., Parks, L.A., and Coon, H.G. (1980) Culture of hormone dependent functional epithelial cells from rat thyroids. Proc. Natl Acad. Sci. USA, 77:3455-3459.
5. Bosher, J.M., Williams, T., and Hurst, H.C. (1995) The developmentally regulated transcription factor AP-2 is involved in c-erbB-2 overexpression in human mammary carcinoma. Proc. Natl Acad. Sci. USA, 92:744-747.
6. Carraway, K.L. III, Sliwkowski, M.X., Akita, R., Platko, J.V., Guy, P.M., Nuijens, A., Diamonti, A.J., Vandlen, R.L., Cantley, L.C., and Cerione, R.A. (1994) The erbB-3 gene product is a receptor for heregulin. J. Biol. Chem., 269:14303-14306.
7. Carraway, K.L. III, and Burden, S. (1995) Neuregulins and their receptors. Current Opinion in Neurobiology, 5:606-612.
8. Carraway, K.L. III, Soltoff, S.P., Diamonti, A.J., and Cantley, L.C. (1995) Heregulin stimulates mitogenesis and phosphatidylinositol 3-kinase in mouse fibroblasts transfected with erbB-2/neu and erbB-3. J. Biol. Chem., 270:7111-7116.
9. Chomczynski, P., and Sacchi, N. (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162:156-159.
10. Ciardiello, F., Tortora, G., Bianco, C., Selvam, M.P., Basolo, F., Fontanini, G., Pacifico, F., Normanno, N., Brandt, R., Persico, M.G. (1994) Inhibition of cripto expression and tumorigenicity in human colon cancer cells by antisense RNA and oligodeoxynucleotides. Oncogene, 9:291-298.
11. Ciccodicola, A., Dono, R., Obici, S., Zollo, M., and Persico, M.G. (1989) Molecular characterization of a gene of the EGF family expressed in undifferentiated human NTERA-2 teratocarcinoma cells. EMBO J., 8:1987-1991.
12. Colletta, G., Pinto, A., Di Fiore, P.P., Fusco, A., Ferrentino, M., Avvedimento, E.A., Vecchio, G., and Tsuchida, N. (1983) Dissociation between transformed and differentiation phenotype in rat epithelial cells after transformation with a temperature-sensitive mutant of the Kirsten murine sarcoma virus. Mol. Cell. Biol., 3:2099-2109.
13. Colletta, G., Cirafici, A.M., Di Carlo, A., Ciardiello, F., Salomon, D.S., and Vecchio, G. (1991) Constitutive expression of TGFα does not transform rat thyroid epithelial cells. Oncogene, 6:583-587.
14. Coppa, A., Mincione, G., Lazzereschi, D., Ranieri, A., Turco, A., Lucignano, B., Scarpa, S., Ragano-Caracciolo, M., and Colletta, G. (1997) Restored expression of Transforming Growth Factor β type II receptor in K-ras transformed thyroid cells, TGFβ resistant, reverts their malignant phenotype. J. Cell. Phys., 172:200-208.
15. Fagin, J.A. (1992) Genetic basis of endocrine disease: Molecular effects in thyroid gland neoplasia. J. Clin. Endocrinol. Metab., 75:1398-1400.
16. Fusco, A., Pinto, A., Tramontano, D., Tajana, G., Vecchio, G., and Tsuchida, N. (1982) Transformation of rat thyroid epithelial cells by kirsten murine sarcoma virus. Cancer Res., 42:618-625.
17. Gassmann, M., and Lemke, G. (1997) Neuregulins and neuregulin receptors in neural development. Current Opinion in Neurobiology, 7:87-92.
18. Haugen, D.R., Akslen, L.A., Varhaug, J.E., and Lillehaug, J.R. (1992) Expression of c-erbB-2 protein in papillary thyroid carcinomas. Br. J. Cancer, 65:832-837.
19. Haugen, D.R.F., Akslen, L.A., Varhaug, J.E., and Lillehaug, J.R. (1993) Demonstration of TGFα-EGF-receptor autocrine loop and c-myc protein overexpression in papillary thyroid carcinomas. Int. J. Cancer, 55:37-43.
20. Haugen, D.R.F., Akslen, L.A., Varhaug, J.E., and Lillehaug, J.R. (1996) Expression of c-erbB-3 and c-erbB-4 protein in papillary thyroid carcinomas. Cancer Res., 56:1184-1188.
21. erbB-2. Science, 256:1205-1210.
22. Howell, G.M., Sun, L.Z., Ziober, B.L., Wu, S.P., Brattain, M.G. (1993) The role of growth regulatory aberrations in progression of human colon carcinoma. Cancer Metastasis Rev., 12:275-286.
23. Kannan, P., Buettner, R., Chiao, P.J., Yim, S.O., Sarkiss, M., and Tainsky, M.A. (1994) N-ras oncogene causes AP-2 transcriptional self-interference, which leads to transformation. Genes Dev., 49:1258-1269.
24. Kannan, S., DeSantis, M., Lohmeyer, M., Riese, II D.J., Smith, G., Hynes, N., Seno, M., Brandt, R., Bianco, C., Persico, G., Kenney, N., Normanno, N., Martinez-Lacaci, I., Ciardiello, F., Stern, D.F., Gullick, W.J., and Salomon, D.S. (1997) Cripto enhances the tyrosine phosphorylation of she and activates MAP-kinase in mammary epithelial cells. J. Biol. Chem., 272:3330-3335.
25. Kraus, M.H., Popescu, N.C., Amsbaugh, S.C., and King, R.C. (1987) Overexpression of the EGF receptor related protooncogene erbB-2 in human mammary tumor cell lines by different molecular mechanisms. EMBO J., 6:605-610.
26. Kraus, M.H., Issing, W., Miki, T., Popescu, N.C., and Aaronson, S.A. (1989) Isolation and characterization of erbB-3, a third member of the erbB/epidermal growth factor receptor family: Evidence for overexpression in a subset of human mammary tumors. Proc. Natl Acad. Sci. USA, 86:9193-9197.
27. Lemoine, N.R., Wyllie, F.S., Lillehaug, J.R., Staddon, S.L., Hughes, C.M., Aasland, R., Shaw, J., Varhaug, J.E., Brown, C.L., Gullick, W.J., and Wynford-Thomas, D. (1990) Absence of abnormalities of the c-erbB-1 and c-erbB-2 protooncogenes in human thyroid neoplasia. Eur. J. Cancer, 26:777-779.
28. Mincione, G., Cirafici, A.M., Lazzareschi, D., Pepe, S., Ciardiello, F., and Colletta, G. (1993) Loss of thyrotropin regulation and transforming growth factor β-induced growth arrest in erbB-2 overexpressing rat thyroid cells. Cancer Res., 53:5548-5553.
29. Mincione, G., Bianco, C., Kannan, S., Colletta, G., Ciardiello, F., Sliwkowski, M., Yarden, Y., Normanno, N., Pramaggiore, A., Kim, N., and Salomon, D.S. (1996) Enhanced expression of heregulin in c-erbB-2 and c-Ha-ras transformed mouse and human mammary epithelial cells. J. Cell. Biochem., 60:437-446.
30. Normanno, N., Kim, N., Wen, D., Smith, K., Harris, A.L., Plowman, G., Colletta, G., Ciardiello, F., and Salomon, D.S. (1995) Expression of messenger RNA for amphiregulin, heregulin, and cripto-1, three new members of the epidermal growth factor family, in human breast carcinomas. Breast Cancer Res. and Treat., 35:293-297.
31. Peles, E., Bacus, S.S., Koski, R.A., Lu, H.S., Wen, D., Ogden, S.G., Ben-Lewy, R., and Yarden, Y. (1992) Isolation of the neu/erbB-2 stimulatory ligand: A 44 Kd glicoprotein that induces differentiation of mammary tumor cells. Cell, 69:205-216.
32. erbB-4. Nature, 366:473-475.
33. Salomon, D.S., Ciardiello, F., Valverius, E.M., and Kim, N. (1991) The role of ras gene expression and transforming growth factor a production in the etiology and progression of rodent and human breast cancer. In: Lippman M., Dickson R., eds. Regulatory Mechanism in Breast Cancer. Boston: Kluwer, 107-157.
34. Salomon, D.S., Brandt, R., Ciardiello, F., and Normanno, N. (1995) Epidermal growth factor-related peptides and their receptors in human malignancies. Critical Reviews in Oncology/Hematology, 19:183-232.
35. Skinner, A., and Hurst, H.C. (1993) Transcriptional regulation of the c-erbB-3 gene in human breast carcinoma cell lines. Oncogene, 8:3393-3401.
36. Slamon, D.J., Clark, G.M., Wong, S.G., Wendy, J.L., Ullirich, A., and McGuire, W.L. (1987) Human breast cancer: Correlation of relapse and survival with amplification of the erbB-2/neu oncogene. Science, 235:177-182.
37. Sliwkowski, M.X., Schaefer, G., Akita, R.W., Lofgren, J.A., Fitzpatrick, V.D., Nuijens, A., Fendly, B.M., Cerione, R.A., Vandlen, R.L., and Carraway, K.L. III (1994) Coexpression of erbB-2 and erbB-3 reconstitutes a high affinity receptor for heregulin. J. Biol. Chem., 269:14661-14665.
38. Tzahar, E., Levkowitz, G., Karunagaran, D., Yi, L., Peles, E., Lavi, S., Chang, D., Liu, N., Yayon, A., Wen, D., and Yarden, Y. (1994) ErbB-3 and ErbB-4 function as the respective low and high affinity receptors of all neu differentiation factor/heregulin isoforms. J. Biol. Chem., 269:26226-25233.
39. Wallasch, C., Weiß, F.U., Niederfellner, G., Jallal, B., Issing, W., and Ullrich, A. (1995) Heregulin-dependent regulation of erbB-2/neu oncogenic signaling by heterodimerization with erbB-3. EMBO J., 14:4267-4275.
40. Wen, D., Peles, E., Cupples, R., Suggs, S., Bacus, S., Luo, Y., Trail, G., Hu, S., Silbiger, S.M., Ben Levy, R., Koski, R.A., Lu, H.S., and Yarden, Y. (1992) Neu differentiation factor: A transmembrane glycoprotein containing an EGF domain and an immunoglobulin homology unit. Cell, 69:559-572.
41. Yarden, Y., and Weinberg, R.A. (1989) Experimental approaches to hypothetical hormones: Detection of a candidate ligand of the new protooncogene. Proc. Natl Acad. Sci. USA, 86:3179-3183.
42. Zimonjic, D.B., Alimandi, M., Miki, T., Popescu, N.C., and Kraus, M.H. (1995) Localization of the human HER-4/erbB-4 gene to chromosome 2. Oncogene, 10:1235-1237.